Form 4 for PLSE PULSE BIOSCIENCES, INC.
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001437749-23-032198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-15 | 2023-11-13 | PLSE | Zanganeh Mahkam | Dir | M - OptEx | $2.14 | +76.1K | 604.9K | +14% | +$162.8K |
| DM | 2023-11-15 | 2023-11-13 | PLSE | Zanganeh Mahkam | Dir | M - OptEx | $0.00 | -76.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-13 | M | A | 20,000 | $2.14 | 548,836 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-13 | M | A | 56,075 | $2.14 | 604,911 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-11-13 | M | D | 20,000 | $0.00 | 0 | D | $2.14 · — to 2032-05-19 | 20,000 Common Stock | (F1) Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a monthly basis following the Company's 2022 Annual Stockholder Meeting. |
| 4 | Derivative | Stock Option (right to buy) | 2023-11-13 | M | D | 56,075 | $0.00 | 0 | D | $2.14 · — to 2032-05-19 | 56,075 Common Stock | (F2) Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a quartetrly basis following the Company's 2022 Annual Stockholder Meeting. |